Respiri (ASX:RSH) is pleased to announce that a major North Carolina based health care organisation has begun enrolling Chronic Obstructive Pulmonary Disease patients in their wheezo® Remote Patient Monitoring (RPM) program.
This program is intended to provide remote management of respiratory diseases to reduce hospital re-admissions.
Revenues from RPM Current Procedural Terminology reimbursement codes will flow to Respiri and Access Telehealth in the next few months.
Respiri is also in advanced discussions with other potential customers in order to extend care beyond the clinic and promote improved health outcomes.